Literature DB >> 33373433

Previous dengue infection and mortality in COVID-19.

Odilson M Silvestre1, Letícia R Costa1, Bianca V R Lopes1, Mariana R Barbosa1, Kárenn K P Botelho1, Kelvyn L C Albuquerque1, Anna G S Souza1, Lorran A Coelho1, Anderson J de Oliveira1, Cínthia B Barantini1, Sebastião A V M Neves1, Wilson Nadruz2, James H Maguire3, Miguel M Fernandes-Silva4.   

Abstract

We studied 2351 participants with COVID-19, 1177 (50%) reported previous dengue infection. Those without previous dengue had a higher risk of death (hazard ratio: 0.44; 95% CI: 0.22 to 0.89; p = 0.023) in 60-day follow-up. These findings raise the possibility that dengue might induce immunological protection against SARS COV-2.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; dengue; mortality

Year:  2020        PMID： 33373433     DOI： 10.1093/cid/ciaa1895

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19.

Authors:  Yean Kong Yong; Won Fen Wong; Ramachandran Vignesh; Indranil Chattopadhyay; Vijayakumar Velu; Hong Yien Tan; Ying Zhang; Marie Larsson; Esaki M Shankar
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  Anti-dengue Potential of Mangiferin: Intricate Network of Dengue to Human Genes.

Authors:  K Kalaimathi; J Maria Jancy Rani; S Vijayakumar; N Prakash; K Karthikeyan; G Thiyagarajan; K Bhavani; S Prabhu; G Varatharaju
Journal:  Rev Bras Farmacogn       Date:  2022-05-07       Impact factor: 2.464

3.  No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.

Authors:  Philipp Kohler; Hulda R Jonsdottir; Rahel Ackermann-Gäumann; Christian R Kahlert; Lorenz Risch; Pietro Vernazza
Journal:  Sci Rep       Date:  2021-12-17       Impact factor: 4.379

4.  Assessment of the clinical and laboratorial profile of patients with obesity and asymptomatic COVID-19 undergoing bariatric surgery in Brazil.

Authors:  Fernando Santa-Cruz; José Guido C Araújo-Júnior; Luciana T Siqueira; Luís H A Leão; Cássio Vianna; Amanda C A Almeida; Maciana S Silva; Flávio Kreimer; Álvaro A B Ferraz
Journal:  Obes Surg       Date:  2022-02-28       Impact factor: 3.479

5.  False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand.

Authors:  Viravarn Luvira; Pornsawan Leaungwutiwong; Narin Thippornchai; Charin Thawornkuno; Supawat Chatchen; Wiwat Chancharoenthana; Sarunporn Tandhavanant; Sant Muangnoicharoen; Watcharapong Piyaphanee; Narisara Chantratita
Journal:  Trop Med Infect Dis       Date:  2022-07-12

6.  COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test.

Authors:  Himadri Nath; Abinash Mallick; Subrata Roy; Tathagata Kayal; Sumit Ranjan; Susanta Sengupta; Soumi Sukla; Subhajit Biswas
Journal:  Int J Infect Dis       Date:  2022-07-08       Impact factor: 12.074
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.